Gastrointestinal Diseases Therapeutics Market size to grow by USD 1.60 billion from 2021 to 2026, Driven by the growth in gastrointestinal diseases - Technavio

NEW YORK, April 11, 2023 /PRNewswire/ -- The gastrointestinal diseases therapeutics market size is forecast to increase by USD 1.60 billion from 2021 to 2026, at a CAGR of 6.68%, according to the recent market study by Technavio. The growth of the market will be driven by the increasing incidence of gastrointestinal diseases, new product launches, and the increasing demand for biologics and targeted therapies. Technavio offers an up-to-date analysis of the current global market scenario and the overall market environment. View a Sample Report 

Vendor Analysis:

The global gastrointestinal diseases therapeutics market has the presence of several global and local vendors. Technavio has extensively analyzed 15 major vendors, including Abbott Laboratories, AbbVie Inc., AstraZeneca Plc, Bausch Health Co Inc., Bayer AG, Biogen Inc., Boston Scientific Corp., C. H. Boehringer Sohn AG and Co. KG, Eisai Co. Ltd., Eli Lilly and Co., Evoke Pharma Inc, GlaxoSmithKline Plc., Johnson and Johnson, Merck and Co. Inc., Novartis AG, Olympus Corp., OVESCO ENDOSCOPY AG, Pfizer Inc., Takeda Pharmaceutical Co. Ltd., UCB SA 

Vendor Offerings -

• Abbott Laboratories - The company offers gastrointestinal diseases therapeutics through its tablets such as Actnew, Adiza, and Cremalax. 
• AbbVie Inc. - The company offers gastrointestinal diseases therapeutics under the brands ACTIGALL and ASACOL HD. 
• AstraZeneca Plc - The company offers gastrointestinal diseases therapeutics such as Fasenra HUDSON and Enhertu DESTINY Gastric01. 

Data about several vendors have been covered in this report. Download the Sample Report

Key Benefits for Industry Players & Stakeholders – 

• The report offers information on the criticality of vendor inputs, including R&D, CAPEX, and technology.
• It also provides detailed analyses of the market's competitive landscape and vendors' product offerings.
• The report also provides a qualitative and quantitative analysis of vendors to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

Expand operations in the future - To get requisite details, ask for a custom report.

Gastrointestinal diseases therapeutics Market - Market Segmentation:

The report extensively covers gastrointestinal diseases therapeutics market segmentation by product (anti-inflammatory and immunosuppressors, acid neutralizers, and other therapeutics) and geography (North America, Europe, Asia, and the Rest of the World (ROW)).

• The market share growth by the anti-inflammatory and immunosuppressors segment will be significant for the market growth during the forecast period. Anti-inflammatory and immunosuppressors are used for the treatment of patients with IBDs. The factors contributing to the growth of the anti-inflammatory and immunosuppressors segment of the global gastrointestinal diseases therapeutics market are the rising prevalence of ulcerative colitis and Crohn's disease, the rising focus of vendors on developing biologics, and effective treatment results among the patients with IBDs. For instance, Crohn's disease involves the inflammation of the lining of the digestive tract of people, and the inflammation in IBDs leads to moderate to severe abdominal pain. Corticosteroids and aminosalicylates are majorly used anti-inflammatory drug types in the case of IBDs, depending on the intensity of the pain and the severity of inflammation.

Get a holistic overview of the market segments from industry experts to evaluate and develop growth strategies. Download the Sample

Market Dynamics:

The increasing incidence of gastrointestinal diseases is notably driving the gastrointestinal diseases therapeutics market growth, with a strong product pipeline being a gastrointestinal diseases therapeutics market trend. Although factors such as the high cost of therapeutics may impede the market growth.

Key Drivers:

• One of the primary factors driving growth in the gastrointestinal diseases therapeutics market is the increasing incidence of gastrointestinal diseases.
• Irritable bowel disease (IBD), gastroesophageal reflux disease (GERD), and other gastrointestinal conditions such as fissures, hemorrhoids, and gallstones are on the rise worldwide.
• The primary contributors to the rising prevalence of chronic and acute gastrointestinal diseases are poor diet, inactivity, stress, food sensitivity, and infection with bacteria or viruses.
• The demand for various medications, such as antacids, histamine H2-receptor antagonists, laxatives, proton pump inhibitors, and antibiotics, to treat and prevent further medical complications from various gastrointestinal diseases, has increased due to their rising incidence and prevalence.
• The demand for various classes or types of drugs to treat gastrointestinal diseases is rising, which is boosting the global market.

Major Trends:

• The strong product pipeline is a gastrointestinal diseases therapeutics market trend that is expected to have a positive impact during the forecast period.
• The need for advanced therapeutics is being fueled by the rising prevalence of severe to moderate gastrointestinal diseases such as Crohn's disease, ulcerative colitis, and others.
• In order to expand their product pipeline, pharmaceutical and biotechnology companies are focusing on research and development (R&D) in order to discover and develop new products for the treatment of gastrointestinal diseases.
• During the forecast period, the growth opportunities in the global gastrointestinal diseases therapeutics market are anticipated to be driven by the growing focus of businesses on the development of novel therapeutics that effectively treat gastrointestinal diseases.
• Hence, during the forecast period, it is anticipated that the growing development of drugs for gastrointestinal diseases by regional and global vendors will significantly boost the expansion of the global therapeutics market for gastrointestinal diseases.

Key Challenges:

• The high cost of therapeutics will be a major challenge impeding the gastrointestinal diseases therapeutics market growth during the forecast period. 
• Biologics and little particles are utilized for the treatment of different gastrointestinal illnesses.
• Chronic IBS includes conditions such as Crohn's disease and ulcerative colitis, both of which necessitate prolonged treatment to reduce the likelihood of recurrence and the development of cancer.
• The total cost of treatments for gastrointestinal diseases includes the cost of drugs, fees for doctors, and hospital stays or visits.
• A wide range of chronic gastrointestinal diseases is treated with biologic drugs such as infliximab and vedolizumab. Infliximab (Remicade, Johnson & Johnson) typically costs between USD 6,000 and USD 6,500, and vedolizumab (Entyvio, Takeda Pharmaceutical) typically costs between USD 8,500 and USD 8,700. 
• Biologics used to treat IBD typically cost between USD 2,500 and USD 5,500 per month.
• The growth of the global market for therapeutics for gastrointestinal diseases is anticipated to be limited to some extent due to rising out-of-pocket costs associated with gastrointestinal disease treatments and procedures.

To get detailed insights about inclusions and exclusions, buy the report 

What are the key data covered in this gastrointestinal diseases therapeutics market report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the gastrointestinal disease therapeutics market between 2022 and 2026
• Precise estimation of the size of the gastrointestinal disease therapeutics and its contribution to the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the gastrointestinal disease therapeutics across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information about vendors
• Comprehensive analysis of factors that will challenge the growth of gastrointestinal disease therapeutics vendors

Gain instant access to 17,000+ market research reports. 
Technavio's SUBSCRIPTION platform

Related Reports:

The gastrointestinal bleeding treatment market size is expected to increase by USD 188.19 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 4.63%. The report extensively covers gastrointestinal bleeding treatment market segmentation by product (endoscopic mechanical devices, endoscopic thermal devices, and others) and geography (North America, Europe, Asia, and Rest of World (ROW)). The favorable initiatives and increasing prevalence of gastrointestinal diseases are notably driving the gastrointestinal bleeding treatment market growth.

The gastrointestinal stromal tumors therapeutics market size is expected to increase by USD 1.08 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 5.97%. the report extensively covers the gastrointestinal stromal tumors therapeutics market segmentation by route of administration (oral and parenteral) and geography (North America, Europe, Asia, and the Rest of the World (ROW)). The growing geriatric population is one of the key factors driving the gastrointestinal stromal tumors therapeutics (GIST) market growth.

Browse for Technavio's Health Care Market Reports          

Table of contents

1 Executive Summary

• 1.1 Market overview 
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
• Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem 
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition 
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 13: Market segments

• 3.3 Market size 2021

• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 14: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary 
• Exhibit 18: Five forces analysis - Comparison between 2021 and 2026

• 4.2 Bargaining power of buyers 
• Exhibit 19: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

• 4.3 Bargaining power of suppliers 
• Exhibit 20: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

• 4.4 Threat of new entrants 
• Exhibit 21: Threat of new entrants – Impact of key factors in 2021 and 2026

• 4.5 Threat of substitutes 
• Exhibit 22: Threat of substitutes – Impact of key factors in 2021 and 2026

• 4.6 Threat of rivalry 
• Exhibit 23: Threat of rivalry – Impact of key factors in 2021 and 2026

• 4.7 Market condition 
• Exhibit 24: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Distribution Channel

• 5.1 Market segments 
• Exhibit 25: Chart on Distribution Channel - Market share 2021-2026 (%)
• Exhibit 26: Data Table on Distribution Channel - Market share 2021-2026 (%)

• 5.2 Comparison by Distribution Channel 
• Exhibit 27: Chart on Comparison by Distribution Channel
• Exhibit 28: Data Table on Comparison by Distribution Channel

• 5.3 Offline - Market size and forecast 2021-2026
• Exhibit 29: Chart on Offline - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Data Table on Offline - Market size and forecast 2021-2026 ($ million)
• Exhibit 31: Chart on Offline - Year-over-year growth 2021-2026 (%)
• Exhibit 32: Data Table on Offline - Year-over-year growth 2021-2026 (%)

• 5.4 Online - Market size and forecast 2021-2026
• Exhibit 33: Chart on Online - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Data Table on Online - Market size and forecast 2021-2026 ($ million)
• Exhibit 35: Chart on Online - Year-over-year growth 2021-2026 (%)
• Exhibit 36: Data Table on Online - Year-over-year growth 2021-2026 (%)

• 5.5 Market opportunity by Distribution Channel
• Exhibit 37: Market opportunity by Distribution Channel ($ million)

6 Market Segmentation by Product

• 6.1 Market segments 
• Exhibit 38: Chart on Product - Market share 2021-2026 (%)
• Exhibit 39: Data Table on Product - Market share 2021-2026 (%)

• 6.2 Comparison by Product 
• Exhibit 40: Chart on Comparison by Product
• Exhibit 41: Data Table on Comparison by Product

• 6.3 Denture cleansing tablet - Market size and forecast 2021-2026 
• Exhibit 42: Chart on Denture cleansing tablet - Market size and forecast 2021-2026 ($ million)
• Exhibit 43: Data Table on Denture cleansing tablet - Market size and forecast 2021-2026 ($ million)
• Exhibit 44: Chart on Denture cleansing tablet - Year-over-year growth 2021-2026 (%)
• Exhibit 45: Data Table on Denture cleansing tablet - Year-over-year growth 2021-2026 (%)

• 6.4 Toothpaste tablet - Market size and forecast 2021-2026 
• Exhibit 46: Chart on Toothpaste tablet - Market size and forecast 2021-2026 ($ million)
• Exhibit 47: Data Table on Toothpaste tablet - Market size and forecast 2021-2026 ($ million)
• Exhibit 48: Chart on Toothpaste tablet - Year-over-year growth 2021-2026 (%)
• Exhibit 49: Data Table on Toothpaste tablet - Year-over-year growth 2021-2026 (%)

• 6.5 Market opportunity by Product 
• Exhibit 50: Market opportunity by Product ($ million)

7 Customer Landscape

• 7.1 Customer landscape overview 
• Exhibit 51: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

• 8.1 Geographic segmentation 
• Exhibit 52: Chart on Market share by geography 2021-2026 (%)
• Exhibit 53: Data Table on Market share by geography 2021-2026 (%)

• 8.2 Geographic comparison 
• Exhibit 54: Chart on Geographic comparison
• Exhibit 55: Data Table on Geographic comparison

• 8.3 North America - Market size and forecast 2021-2026
• Exhibit 56: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 57: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 58: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 59: Data Table on North America - Year-over-year growth 2021-2026 (%)

• 8.4 Europe - Market size and forecast 2021-2026
• Exhibit 60: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 61: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 62: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 63: Data Table on Europe - Year-over-year growth 2021-2026 (%)

• 8.5 Asia - Market size and forecast 2021-2026
• Exhibit 64: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 65: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 66: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 67: Data Table on Asia - Year-over-year growth 2021-2026 (%)

• 8.6 Rest of World (ROW) - Market size and forecast 2021-2026 
• Exhibit 68: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 69: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 70: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 71: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

• 8.7 US - Market size and forecast 2021-2026
• Exhibit 72: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 73: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 74: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 75: Data Table on US - Year-over-year growth 2021-2026 (%)

• 8.8 China - Market size and forecast 2021-2026
• Exhibit 76: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 77: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 78: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 79: Data Table on China - Year-over-year growth 2021-2026 (%)

• 8.9 Germany - Market size and forecast 2021-2026
• Exhibit 80: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 81: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 82: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 83: Data Table on Germany - Year-over-year growth 2021-2026 (%)

• 8.10 Canada - Market size and forecast 2021-2026
• Exhibit 84: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 85: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 86: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibit 87: Data Table on Canada - Year-over-year growth 2021-2026 (%)

• 8.11 UK - Market size and forecast 2021-2026
• Exhibit 88: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 89: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 90: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibit 91: Data Table on UK - Year-over-year growth 2021-2026 (%)

• 8.12 Market opportunity by geography 
• Exhibit 92: Market opportunity by geography ($ million)

9 Drivers, Challenges, and Trends

• 9.1 Market drivers

• 9.2 Market challenges

• 9.3 Impact of drivers and challenges 
• Exhibit 93: Impact of drivers and challenges in 2021 and 2026

• 9.4 Market trends

10 Vendor Landscape

• 10.1 Overview

• 10.2 Vendor landscape 
• Exhibit 94: Overview on Criticality of inputs and Factors of differentiation

• 10.3 Landscape disruption 
• Exhibit 95: Overview on factors of disruption

• 10.4 Industry risks 
• Exhibit 96: Impact of key risks on business

11 Vendor Analysis

• 11.1 Vendors covered 
• Exhibit 97: Vendors covered

• 11.2 Market positioning of vendors 
• Exhibit 98: Matrix on vendor position and classification

• 11.3 Archtek Inc. 
• Exhibit 99: Archtek Inc. - Overview
• Exhibit 100: Archtek Inc. - Product / Service
• Exhibit 101: Archtek Inc. - Key offerings

• 11.4 ChildLife 
• Exhibit 102: ChildLife - Overview
• Exhibit 103: ChildLife - Product / Service
• Exhibit 104: ChildLife - Key offerings

• 11.5 DENTSPLY SIRONA Inc. 
• Exhibit 105: DENTSPLY SIRONA Inc. - Overview
• Exhibit 106: DENTSPLY SIRONA Inc. - Business segments
• Exhibit 107: DENTSPLY SIRONA Inc. - Key news
• Exhibit 108: DENTSPLY SIRONA Inc. - Key offerings
• Exhibit 109: DENTSPLY SIRONA Inc. - Segment focus

• 11.6 GlaxoSmithKline Plc 
• Exhibit 110: GlaxoSmithKline Plc - Overview
• Exhibit 111: GlaxoSmithKline Plc - Business segments
• Exhibit 112: GlaxoSmithKline Plc - Key news
• Exhibit 113: GlaxoSmithKline Plc - Key offerings
• Exhibit 114: GlaxoSmithKline Plc - Segment focus

• 11.7 Johnson and Johnson 
• Exhibit 115: Johnson and Johnson - Overview
• Exhibit 116: Johnson and Johnson - Business segments
• Exhibit 117: Johnson and Johnson - Key news
• Exhibit 118: Johnson and Johnson - Key offerings
• Exhibit 119: Johnson and Johnson - Segment focus

• 11.8 Litesmith 
• Exhibit 120: Litesmith - Overview
• Exhibit 121: Litesmith - Product / Service
• Exhibit 122: Litesmith - Key offerings

• 11.9 Lush Retail Ltd. 
• Exhibit 123: Lush Retail Ltd. - Overview
• Exhibit 124: Lush Retail Ltd. - Product / Service
• Exhibit 125: Lush Retail Ltd. - Key offerings

• 11.10 Prestige Consumer Healthcare Inc.
• Exhibit 126: Prestige Consumer Healthcare Inc. - Overview
• Exhibit 127: Prestige Consumer Healthcare Inc. - Business segments
• Exhibit 128: Prestige Consumer Healthcare Inc. - Key offerings
• Exhibit 129: Prestige Consumer Healthcare Inc. - Segment focus

• 11.11 Reckitt Benckiser Group PLC 
• Exhibit 130: Reckitt Benckiser Group PLC - Overview
• Exhibit 131: Reckitt Benckiser Group PLC - Business segments
• Exhibit 132: Reckitt Benckiser Group PLC - Key offerings
• Exhibit 133: Reckitt Benckiser Group PLC - Segment focus

• 11.12 The Kind Lab 
• Exhibit 134: The Kind Lab - Overview
• Exhibit 135: The Kind Lab - Product / Service
• Exhibit 136: The Kind Lab - Key offerings

12 Appendix

• 12.1 Scope of the report

• 12.2 Inclusions and exclusions checklist
• Exhibit 137: Inclusions checklist
• Exhibit 138: Exclusions checklist

• 12.3 Currency conversion rates for US$ 
• Exhibit 139: Currency conversion rates for US$

• 12.4 Research methodology 
• Exhibit 140: Research methodology
• Exhibit 141: Validation techniques employed for market sizing
• Exhibit 142: Information sources

• 12.5 List of abbreviations 
• Exhibit 143: List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio